TCL Archive MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer. March 2, 2001
TCL Archive Research Funding: Clinton Proposes 2.6% Increase For NIH, Amount Called “Paltry” February 14, 1997
TCL Archive Growth in Research Capacity Explains Increased Competition, NIH Director Tells NCAB. June 16, 2006